Characteristic | Patients (n = 96) |
Male, n (%) | 58 (60%) |
Age (yrs) at time of surgery | 2.1 yrs (0.6 - 8.4) |
Weight (kg) at time of surgery | 10.5 kg (6.6 - 24) |
Ethnicity, n (%) |
|
Caucasian | 31 (32%) |
African American | 35 (37%) |
Hispanic | 26 (27%) |
Asian | 2 (2%) |
Other | 2 (2%) |
Genetic/chromosomal abnormalities, n (%) TOTAL | 26 (27%) |
Trisomy 21 | 7 (7%) |
DiGeorge Syndrome | 6 (6%) |
Other | 13 (13.5%) |
Noncardiac anatomic abnormalities, n (%) | 11 (11%) |
| Procedures (n = 133) |
STAT category, n (%) |
|
STAT 1 | 62 (47%) |
STAT 2 | 38 (29%) |
STAT 3 | 20 (15%) |
STAT 4 | 12 (9%) |
STAT 5 | 1 (1%) |
Preoperative mechanical ventilation, n (%) | 23 (17%) |
Preoperative creatinine (mg/dL) | 0.3 mg/dL (0.25 - 0.46) |
48-h creatinine (mg/dL) | 0.3 mg/dL (0.23 - 0.43) |
Preoperative lactate (mg/dL) | 1.3 mg/dL (0.9 - 2) |
48-h lactate (mg/DL) | 1 mg/dL (0.8 - 1.4) |
Cardiopulmonary bypass duration (min) (15/133 procedures did not require CPB) | 96 min (77 - 120) |
Aortic cross-clamp duration (min) | |
(73/118 procedures that required CPB did not require aortic cross-clamping) | 55.5 min (43.2 - 74) |
Deep hypothermic circulatory arrest, n (%) | 8 (6%) |
Deep hypothermic circulatory arrest (min) | 28 min (10.5 - 38.2) |
ECMO, n (%) | 5/133 (3.8%) |
Postoperative inhaled nitric oxide use, n (%) | 42/133 (32.8%) |
Delayed sternal closure, n (%) | 1/122 (0.8%) |
Deaths |
|
Less than 30 days | 0/122 (0%) |
Less than 90 days | 2/122 (1.6%) |
All deaths | 3/122 (2.5 %) |